OraSure Technologies
The 10-second takeaway
For the quarter ended March 31 (Q1), OraSure Technologies met expectations on revenues and exceeded expectations on earnings per share.
Compared to the prior-year quarter, revenue expanded significantly and GAAP loss per share improved.
Gross margins grew, operating margins dropped, net margins shrank.
Revenue details
OraSure Technologies booked revenue of $20.9 million. The seven analysts polled by S&P Capital IQ expected revenue of $20.9 million on the same basis. GAAP reported sales were 20% higher than the prior-year quarter's $17.4 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
EPS came in at -$0.07. The six earnings estimates compiled by S&P Capital IQ predicted -$0.09 per share. GAAP EPS were -$0.07 for Q1 versus -$0.06 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Margin details
For the quarter, gross margin was 65.6%, 90 basis points better than the prior-year quarter. Operating margin was -17.4%, 270 basis points worse than the prior-year quarter. Net margin was -15.5%, 60 basis points worse than the prior-year quarter.
Looking ahead
Next quarter's average estimate for revenue is $23.8 million. On the bottom line, the average EPS estimate is -$0.05.
Next year's average estimate for revenue is $98.1 million. The average EPS estimate is -$0.19.
Investor sentiment
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 189 members out of 210 rating the stock outperform, and 21 members rating it underperform. Among 57 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 50 give OraSure Technologies a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on OraSure Technologies is buy, with an average price target of $13.58.
The healthcare investing landscape is littered with also-rans and a few major winners. Is OraSure Technologies the right stock for you? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company David Gardner believes will be a phenomenal success over the next few years. Click here for instant access to this free report.
- Add OraSure Technologies to My Watchlist.